We are proud to announce the MSK incoming Complex General Surgical Oncology Fellows for 2027-29. We look forward to training the next generation of leaders in cancer surgery. Welcome to MSK. #SurgicalOncology#MSKCancerCenter
Results from the phase 3 #RASolute302 trial found that #daraxonrasib significantly improved overall survival compared with chemotherapy in previously treated metastatic #pancreaticcancer.
Learn more about the findings and what MSK's @EileenMOReilly says they could mean for the future of pancreatic cancer treatment: https://t.co/w2NhrorSM3
Should we chase margins intraop for PDAC?
✅Yes - R0 is key for cure
❌No - R1 reflects biology, not technical cure
Great summary & sharp debate on surgical cure vs disease reality from #SSO2024 in @AnnSurgOncol between @wei_ac & @DavidKoobyMD
🔗 https://t.co/5ZmqVHMC3l